Pivot to the patient

Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.

We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.

New science: Biopharma’s new growth engine

Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.

READ MORE

New Science | Pharma's New Growth Machine

Accenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.

View Transcript

Case studies

Gene therapy gets personal

Accenture helped a biopharma company implement a patient-centered platform to manage the delivery of a personalized gene therapy solution.

READ MORE

Merck KGaA puts digital at the heart of healthcare

A new SAP S/4 HANA ERP solution ushers Merck KGaA Healthcare into a digital future.

READ MORE

NAVIFY® Tumor Board: improving cancer care

Roche's NAVIFY® Tumor Board is changing the way tumor board meetings are organized.

READ MORE
View All

Awards & recognition

Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.

Everest Group PEAK Matrix Report

Leader in Life Sciences Digital Services

2019

Recognized by Frost & Sullivan

Awarded North American Market Leadership Award - Real World Evidence

2018 Recipient

Recognized by IDC MarketScape

Leader in Life Science R&D Strategic Consulting

2018 Recognition

View All

A spotlight on women in Life Sciences

We are proud to collaborate with leading women in life sciences in their quest to advance science and patient care.

Dr. Saori Watanabe Miyano of Eisai’s Tsukuba Research Laboratories is Senior Director of the Oncology Tsukuba Research Department that spearheads the company’s cancer research. Interested in biology and chemistry at high school and wanting to learn about these subjects in greater depth, she went on to study pharmacology at university. She considered becoming a pharmacist, devoted to helping the patients she encountered in person, or a drug development scientist, so that she could provide better drugs for patients all over the world. Having considered her options, she chose a path that led her to the Tsukuba Research Department at Eisai. Having gained experience as a researcher and steadily advanced in her career, Dr. Watanabe became a Senior Director of the Oncology Business Group in Japan and now heads a team of some 20 scientist. Maintaining regular contact with colleagues at Eisai’s overseas laboratories, she plays a prominent role as one of the company’s female leaders.

READ HER STORY

Life Sciences blog

Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.

The Great Divide: The world of scientists in and out of the lab

Learn more about what’s happening within the life sciences laboratory.

A new commercial model for new patient insights and outcomes

As companies use data to anticipate customer needs, it makes sense that customer expectations will no longer recognize traditional boundaries.

News

Accenture and Google Cloud collaborate to help life sciences companies advance the discovery of innovative therapies

Accenture and Google Cloud announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT™ life sciences industry platform.

UCB and Accenture collaborate to accelerate data processing and help improve patient safety

Accenture and UCB, a global biopharmaceutical company, have collaborated to build a safety solution with Accenture’s INTIENT™ Pharmacovigilance.

Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter